These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21766634)

  • 21. Hyperuricemia and cardiovascular risk.
    Grassi D; Desideri G; Di Giacomantonio AV; Di Giosia P; Ferri C
    High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):235-42. PubMed ID: 24554489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uric acid metabolism in patients with primary gout and the metabolic syndrome.
    Fraile JM; Puig JG; Torres RJ; de Miguel E; Martínez P; Vázquez JJ
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):330-4. PubMed ID: 20544516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
    Brodov Y; Behar S; Boyko V; Chouraqui P
    Am J Cardiol; 2010 Dec; 106(12):1717-20. PubMed ID: 21126615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detrimental role of hyperuricemia on the cardio-reno-vascular system.
    Stack A; Manolis AJ; Ritz E
    Curr Med Res Opin; 2015; 31 Suppl 2():21-6. PubMed ID: 26414733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
    Becker MA
    Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival.
    Martin WJ; Grainger R; Harrison A; Harper JL
    J Rheumatol; 2010 Jun; 37(6):1228-35. PubMed ID: 20395644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the presence of sleep apnoea-hypopnoea syndrome a precursor for gout?
    Marinchev L
    Rheumatology (Oxford); 2013 Sep; 52(9):1547-8. PubMed ID: 23696690
    [No Abstract]   [Full Text] [Related]  

  • 29. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

  • 30. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Thyroid Disorders in Patients with Gout and Hyperuricemia.
    Xu J; Wang B; Li Q; Yao Q; Jia X; Song R; Zhang JA
    Horm Metab Res; 2019 Aug; 51(8):522-530. PubMed ID: 31408898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.
    Wortmann RL; Macdonald PA; Hunt B; Jackson RL
    Clin Ther; 2010 Dec; 32(14):2386-97. PubMed ID: 21353107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sleep apnea syndrome].
    Matsumoto Y
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():266-72. PubMed ID: 12629729
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperuricemia and associated diseases.
    Becker MA; Jolly M
    Rheum Dis Clin North Am; 2006 May; 32(2):275-93, v-vi. PubMed ID: 16716880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin resistance syndrome in patients with gout and its influence on formation of clinical characteristics of the disease].
    Barskova VG; Eliseev MS; Nasonov EL; Iakunina IA; Zilov AV; Il'inykh EV
    Ter Arkh; 2004; 76(5):51-6. PubMed ID: 15230133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First acute gout attacks commonly precede features of the metabolic syndrome.
    Hernández-Cuevas CB; Roque LH; Huerta-Sil G; Rojas-Serrano J; Escudero A; Perez LL; Collantes-Estevez E; Vázquez Mellado J
    J Clin Rheumatol; 2009 Mar; 15(2):65-7. PubMed ID: 19265347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between serum uric acid concentration and metabolic syndrome in university freshmen.
    Lin KP
    J Nurs Res; 2009 Dec; 17(4):286-92. PubMed ID: 19955885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of hearing levels in gout patients and factors affecting hearing levels such as the dislipidemia, hemoglobin levels and hyperuricemia.
    Yücel A; Yücel H; Aydemir F; Cüre E; Eryılmaz MA; Çizmecioğlu HA; Küçük A
    Am J Otolaryngol; 2020; 41(5):102565. PubMed ID: 32563785
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathogenesis and management of hyperuricemia in metabolic syndrome].
    Fujimori S
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():438-44. PubMed ID: 17458259
    [No Abstract]   [Full Text] [Related]  

  • 40. Gout, diet, and the insulin resistance syndrome.
    Fam AG
    J Rheumatol; 2002 Jul; 29(7):1350-5. PubMed ID: 12136887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.